Moreover, we showed that DNA methylation landscape of ADCY4, CPXM1, DNM3, PRDM14, PRKCB, and ZNF177 could be selected as accurate biomarkers for the prognosis of breast cancer. This evidence concerns the gene PRKCB and breast carcinoma.